![](/img/cover-not-exists.png)
PD-081 A phase 2 randomized study of GM-CSF gene-modifiedautologous tumor vaccine (CG8123) with and without low-dose cyclophosphamide in advanced stage non-small cell lung cancer (NSCLC)
Schiller, J., Nemunaitis, J., Ross, H., Jablons, D., Harper, H., Sterman, D., Kelly, K., Carbone, D., Lin, A., Hege, K.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80414-3
Date:
July, 2005
File:
PDF, 276 KB
english, 2005